ER stress-related mRNA-lncRNA co-expression gene signature predicts the prognosis and immune implications of esophageal cancer

被引:1
|
作者
Li, Feng [1 ]
Ma, Jiahao [1 ]
Yan, Cheng [1 ]
Qi, Yonghua [1 ]
机构
[1] Xinxiang Univ, Diagnost Lab Anim Dis, Key Lab Nanocarbon Modified Film Technol Henan Pr, Sch Pharm, Xinxiang, Henan, Peoples R China
来源
关键词
Esophageal cancer; endoplasmic reticulum stress; mRNA; lncRNA; prognostic model; TUMOR-GROWTH; CELLS; MICROENVIRONMENT; IDENTIFICATION; EXPRESSION; INHIBITOR; CARCINOMA; APOPTOSIS; NETWORK; ROLES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Esophageal cancer (EC) is one of the most common malignant cancers in the world. Endoplasmic reticulum (ER) stress is an adaptive response to various stress conditions and has been implicated in the development of various types of cancer. Long noncoding RNAs (lncRNAs) refer to a group of noncoding RNAs (ncRNAs), which regulate gene expression by interacting with DNA, RNA and proteins. Accumulating evidence suggests that lncRNAs are critical regulators of gene expression in development, differentiation, and human diseases, such as cancers and heart diseases. However, the prognostic model of EC based on ER stress-related mRNA and lncRNA has not been reported. Methods: Firstly, we downloaded RNA expression profiles from The Cancer Genome Atlas (TCGA) and obtained ER stress-related genes from the Molecular Signature Database (MSigDB). Next, Weighted Correlation Network Analysis (WGCNA) co-expression analysis was used to identify survival-related ER stress-related modules. Prognostic models were developed using univariate and Least absolute shrinkage and selection operator (LASSO) regression analyses on the training set and validated on the test set. Afterwards, The Receiver Operating Characteristic (ROC) curve and nomogram were used to evaluate the performance of risk prediction models. Differentially expressed gene (DEG) and enrichment analysis were performed between different groups in order to identify the biological processes correlated with the risk score. Finally, the fraction of immune cell infiltration and the difference of tumor microenvironment were identified in high-risk and low-risk groups. Results: The WGCNA co-expression analysis identified 49 ER genes that are highly associated with EC prognosis. Using univariate Cox regression and LASSO regression analysis, we developed prognostic risk models based on nine signature genes (four mRNAs and five lncRNAs). Both in the training and in the test sets, the overall survival (OS) of EC patients in the high-risk group was significantly lower than that in the low-risk group. The Kaplan-Meier curve and the ROC curve demonstrate the prognostic model we built can precisely predict the survival with more than 70% accuracy. The correlation analysis between the risk score and the infiltration of immune cells showed that the model can indicate the state of the immune microenvironment in EC. Conclusion: In this study, we developed a novel prognostic model for esophageal cancer based on ER stress-related mRNA-lncRNA co-expression profiles that could predict the prognosis, immune cell infiltration, and immunotherapy response in patients with EC. Our results also may provide clinicians with a quantitative tool to predict the survival time of patients and help them individualize treatment strategies for the patients with EC.
引用
收藏
页码:8064 / +
页数:28
相关论文
共 50 条
  • [41] A Prognostic Risk Model of a Novel Oxidative Stress-Related Signature Predicts Clinical Prognosis and Demonstrates Immune Relevancy in Lung Adenocarcinoma
    Huang, Xing
    Lu, Zhichao
    He, Min
    Feng, Yipeng
    Yu, Shaorong
    Shen, Bo
    Lu, Jianwei
    Wu, Pingping
    Pan, Banzhou
    Ding, Hanlin
    Chen, Chen
    Sun, Yidan
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [42] A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer
    Qing Wu
    Xuan Tao
    Yang Luo
    Shiyao Zheng
    Nan Lin
    Xianhe Xie
    BMC Cancer, 23
  • [43] Comment on "A novelsuper-enhancer-related gene signature predicts prognosis and immune microenvironment forbreast cancer"
    Chehelgerdi, Matin
    Khorramian-Ghahfarokhi, Milad
    Dehkordi, Fereshteh Behdarvand
    Chehelgerdi, Mohammad
    BMC CANCER, 2024, 24 (01)
  • [44] A Cholesterol Homeostasis-Related Gene Signature Predicts Prognosis of Endometrial Cancer and Correlates With Immune Infiltration
    Chen, Yili
    Lee, Kaping
    Liang, Yanchun
    Qin, Shuhang
    Zhu, Yuan
    Liu, Junxiu
    Yao, Shuzhong
    FRONTIERS IN GENETICS, 2021, 12
  • [45] Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer
    Weng, Jin-Sen
    Huang, Jie-Ping
    Yu, Wei
    Xiao, Jun
    Lin, Fang
    Lin, Kang-Ni
    Zang, Wei-Dong
    Ye, Yong
    Lin, Jing-Ping
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (03) : 546 - 561
  • [46] An Immunogenic Cell Death-Related Gene Signature Predicts the Prognosis and Immune Infiltration of Cervical Cancer
    Sun, Fangfang
    Sun, Yuanyuan
    Tian, Hui
    CANCER INFORMATICS, 2025, 24
  • [47] A novel super-enhancer-related gene signature predicts prognosis and immune microenvironment for breast cancer
    Wu, Qing
    Tao, Xuan
    Luo, Yang
    Zheng, Shiyao
    Lin, Nan
    Xie, Xianhe
    BMC CANCER, 2023, 23 (01)
  • [48] A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer
    Zhao, Ruijun
    Xie, Chaoyu
    Gong, Yu
    Wei, Songzhi
    Yuan, Mei
    Gan, Jinfeng
    Chen, Wenyan
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [49] Identifying Biomarkers of Immune Signature Related to Smoking and Overall Survival in NSCLC on Gene Co-Expression Network
    Song, R.
    Cheng, X.
    Lian, B.
    Zhang, X.
    Zhang, J.
    Li, K.
    Fu, W.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S407 - S407
  • [50] Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer
    Jin-Sen Weng
    Jie-Ping Huang
    Wei Yu
    Jun Xiao
    Fang Lin
    Kang-Ni Lin
    Wei-Dong Zang
    Yong Ye
    Jing-Ping Lin
    World Journal of Gastrointestinal Oncology, 2023, (03) : 546 - 561